top of page

Weigh Loss and Wegovy

Weight loss is a topic that has been on the minds of many people for years. The idea of losing weight can be overwhelming for some, and they may not know where to start. However, there are many methods available to help individuals lose weight, including dietary changes, exercise, and medication. One medication that has recently gained popularity in the weight loss community is Wegovy.


Wegovy, also known as semaglutide, is a medication that was approved by the US Food and Drug Administration (FDA) in June 2021 for weight management in adults who have obesity or are overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. Semaglutide was previously used to treat type 2 diabetes, but its weight loss effects were discovered during clinical trials.

How does Wegovy work?


Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone that is released from the gut in response to food intake. It stimulates insulin secretion and reduces glucagon secretion, leading to lower blood sugar levels. GLP-1 also slows down stomach emptying, leading to feelings of fullness and reduced food intake.

Wegovy works by activating the GLP-1 receptors in the brain, leading to reduced appetite and increased feelings of fullness. It also increases the body's sensitivity to insulin, leading to lower blood sugar levels. The medication is administered once a week via subcutaneous injection and is typically used in conjunction with a reduced-calorie diet and increased physical activity.


How effective is Wegovy?


Clinical trials have shown that Wegovy is effective in promoting weight loss. In a study of over 1,900 adults with obesity, those who received Wegovy injections once a week for 68 weeks lost an average of 15% of their body weight, compared to those who received a placebo injection and lost an average of 2.4% of their body weight.

In addition to promoting weight loss, Wegovy has been shown to improve other health outcomes. In clinical trials, participants who received Wegovy had a significant reduction in blood pressure, blood sugar levels, and cholesterol levels.

Are there any side effects of Wegovy?


As with any medication, there are potential side effects of Wegovy. The most common side effects reported during clinical trials were nausea, diarrhea, vomiting, constipation, and abdominal pain. However, these side effects were typically mild to moderate and resolved over time.

More serious side effects are rare but can occur. These include pancreatitis, gallbladder disease, and kidney problems. Patients should speak with their healthcare provider before starting Wegovy to discuss the potential benefits and risks.


Is Wegovy right for you?


Wegovy may be an appropriate option for adults who have obesity or are overweight with at least one weight-related condition and who have not been able to achieve weight loss through diet and exercise alone. However, it is important to note that Wegovy is not a magic pill for weight loss and should be used in conjunction with a reduced-calorie diet and increased physical activity.

Patients should speak with their healthcare provider to determine if Wegovy is right for them. Individuals who have a history of pancreatitis or thyroid cancer, or who are pregnant or breastfeeding, should not take Wegovy.


In conclusion, Wegovy is a medication that has been shown to promote weight loss in adults with obesity or who are overweight with at least one weight-related condition. While it is not a magic pill for weight loss, it can be an effective tool when used in conjunction with a reduced-calorie diet and increased physical activity. Patients should speak with their healthcare provider to determine if Wegovy is right for them and to discuss potential benefits and risks.

11 views0 comments

Comments


bottom of page